Arcellx Stock Investor Sentiment

ACLX Stock  USD 71.68  0.10  0.14%   
Slightly above 56% of Arcellx's investor base is looking to short. The analysis of the overall investor sentiment regarding Arcellx suggests that many traders are alarmed. Arcellx's investing sentiment can be driven by a variety of factors including economic data, Arcellx's earnings reports, geopolitical events, and overall market trends.

Comfort Level 44

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Arcellx's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Arcellx.

Arcellx Historical Sentiment

Although Arcellx's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Arcellx, such as negative comments on social media and news outlets, may cause fear in the market and push Arcellx's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Arcellx.
  

Arcellx Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Arcellx can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Arcellx Historical Investor Sentiment

Investor biases related to Arcellx's public news can be used to forecast risks associated with an investment in Arcellx. The trend in average sentiment can be used to explain how an investor holding Arcellx can time the market purely based on public headlines and social activities around Arcellx. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Arcellx's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Arcellx and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Arcellx news discussions. The higher the estimate score, the more favorable the investor's outlook on Arcellx.

Arcellx Maximum Pain Price Across June 20th 2025 Option Contracts

Arcellx's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Arcellx close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Arcellx's options.
2 days ago at news.google.com         
US Bancorp DE Has 462,000 Holdings in Arcellx, Inc. - Defense World
Google News at Macroaxis
six days ago at thelincolnianonline.com         
Jackson Creek Investment Advisors LLC Buys New Shares in Arcellx, Inc.
news
over a week ago at www.macroaxis.com         
Disposition of 100 shares by Michelle Gilson of Arcellx at 91.67 subject to Rule 16b-3
Macroaxis News
over a week ago at simplywall.st         
Need To Know Analysts Just Made A Substantial Cut To Their Arcellx, Inc. Estimates
Simply Wall St News at Macroaxis
over a week ago at finance.yahoo.com         
Were Not Worried About Arcellxs Cash Burn
Yahoo News
over a week ago at thelincolnianonline.com         
Arcellx, Inc. Insider Sells 2,375,366.00 in Stock
news
over a week ago at simplywall.st         
Arcellx Full Year 2024 Earnings Misses Expectations
Simply Wall St News at Macroaxis
over two weeks ago at zacks.com         
Arcellx, Inc. Reports Q4 Loss, Lags Revenue Estimates
zacks News
over two weeks ago at gurufocus.com         
Decoding Arcellx Inc A Strategic SWOT Insight
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Arcellx Inc Reports Promising Clinical Data and Financial Results for 2024
Gurufocus Stories at Macroaxis
over two weeks ago at seekingalpha.com         
Acquisition by Rami Elghandour of 668416 shares of Arcellx subject to Rule 16b-3
seekingalpha News
over two weeks ago at seekingalpha.com         
Arcellx GAAP EPS of -2.00 misses by 0.40, revenue of 107.94M
seekingalpha News
over two weeks ago at gurufocus.com         
Arcellx Inc to Participate in TD Cowen 45th Annual Health Care Conference
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Disposition of 10889 shares by Rami Elghandour of Arcellx at 62.6894 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over two weeks ago at businesswire.com         
Arcellx to Participate at the TD Cowen 45th Annual Health Care Conference
businesswire News
Far too much social signal, news, headlines, and media speculation about Arcellx that are available to investors today. That information is available publicly through Arcellx media outlets and privately through word of mouth or via Arcellx internal channels. However, regardless of the origin, that massive amount of Arcellx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Arcellx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Arcellx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Arcellx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Arcellx alpha.

Arcellx Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 100 shares by Patel Kavita of Arcellx at 77.61 subject to Rule 16b-3
12/24/2024
2
Disposition of 55459 shares by Rami Elghandour of Arcellx subject to Rule 16b-3
01/02/2025
3
Disposition of 53097 shares by Rami Elghandour of Arcellx subject to Rule 16b-3
01/03/2025
4
Disposition of 13776 shares by Rami Elghandour of Arcellx at 77.1668 subject to Rule 16b-3
01/06/2025
5
Guardant Health Soars 6.3 percent Is Further Upside Left in the Stock
01/07/2025
6
Disposition of 1061 shares by Michelle Gilson of Arcellx at 87.89 subject to Rule 16b-3
01/08/2025
7
Disposition of 300 shares by Patel Kavita of Arcellx at 67.3167 subject to Rule 16b-3
01/14/2025
8
Disposition of 3421 shares by Heery Christopher of Arcellx at 15.0 subject to Rule 16b-3
01/17/2025
9
Disposition of 1500 shares by Patel Kavita of Arcellx at 64.57 subject to Rule 16b-3
02/04/2025
10
Arcellx, Inc. Director Sells 96,855.00 in Stock
02/07/2025
11
Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch For HIV Prevention
02/12/2025
12
Disposition of 208 shares by Heery Christopher of Arcellx at 64.8778 subject to Rule 16b-3
02/24/2025
13
Disposition of 1500 shares by Patel Kavita of Arcellx at 63.16 subject to Rule 16b-3
02/25/2025
14
Arcellx, Inc. Director Kavita Patel Sells 1,500 Shares
02/26/2025
15
Arcellx Inc Reports Promising Clinical Data and Financial Results for 2024
02/27/2025
16
Need To Know Analysts Just Made A Substantial Cut To Their Arcellx, Inc. Estimates
03/05/2025
17
Disposition of 100 shares by Michelle Gilson of Arcellx at 91.67 subject to Rule 16b-3
03/06/2025
18
US Bancorp DE Has 462,000 Holdings in Arcellx, Inc. - Defense World
03/13/2025

Additional Tools for Arcellx Stock Analysis

When running Arcellx's price analysis, check to measure Arcellx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcellx is operating at the current time. Most of Arcellx's value examination focuses on studying past and present price action to predict the probability of Arcellx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcellx's price. Additionally, you may evaluate how the addition of Arcellx to your portfolios can decrease your overall portfolio volatility.